189 related articles for article (PubMed ID: 21680707)
1. Plasma leptin levels and risk of breast cancer in premenopausal women.
Harris HR; Tworoger SS; Hankinson SE; Rosner BA; Michels KB
Cancer Prev Res (Phila); 2011 Sep; 4(9):1449-56. PubMed ID: 21680707
[TBL] [Abstract][Full Text] [Related]
2. [Association of plasma leptin levels and soluble leptin receptor with breast cancer].
Yi F; Diao S; Yuan XL; Li JY
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):253-259. PubMed ID: 29973003
[No Abstract] [Full Text] [Related]
3. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
4. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.
Eliassen AH; Tworoger SS; Mantzoros CS; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):161-4. PubMed ID: 17220346
[TBL] [Abstract][Full Text] [Related]
5. Leptin and leptin receptor genes in relation to premenopausal breast cancer incidence and grade in Caucasian women.
Gu F; Kraft P; Rice M; Michels KB
Breast Cancer Res Treat; 2012 Jan; 131(1):17-25. PubMed ID: 21947707
[TBL] [Abstract][Full Text] [Related]
6. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
7. Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II.
Eliassen AH; Spiegelman D; Hollis BW; Horst RL; Willett WC; Hankinson SE
Breast Cancer Res; 2011 May; 13(3):R50. PubMed ID: 21569367
[TBL] [Abstract][Full Text] [Related]
8. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
9. The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study.
Cust AE; Stocks T; Lukanova A; Lundin E; Hallmans G; Kaaks R; Jonsson H; Stattin P
Breast Cancer Res Treat; 2009 Feb; 113(3):567-76. PubMed ID: 18330696
[TBL] [Abstract][Full Text] [Related]
10. Plasma Anti-Müllerian Hormone Concentrations and Risk of Breast Cancer among Premenopausal Women in the Nurses' Health Studies.
Eliassen AH; Zeleniuch-Jacquotte A; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):854-60. PubMed ID: 26961996
[TBL] [Abstract][Full Text] [Related]
11. Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II.
Harris HR; Willett WC; Terry KL; Michels KB
J Natl Cancer Inst; 2011 Feb; 103(3):273-8. PubMed ID: 21163903
[TBL] [Abstract][Full Text] [Related]
12. The relation of leptin and adiponectin with breast density among premenopausal women.
Maskarinec G; Woolcott C; Steude JS; Franke AA; Cooney RV
Eur J Cancer Prev; 2010 Jan; 19(1):55-60. PubMed ID: 19927000
[TBL] [Abstract][Full Text] [Related]
13. Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.
Graff RE; Cho E; Lindström S; Kraft P; Willett WC; Eliassen AH
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):516-24. PubMed ID: 24443403
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of leptin, adiposity and breast cancer risk.
Wu MH; Chou YC; Chou WY; Hsu GC; Chu CH; Yu CP; Yu JC; Sun CA
Br J Cancer; 2009 Feb; 100(4):578-82. PubMed ID: 19223908
[TBL] [Abstract][Full Text] [Related]
15. Plasma adipokines and endometriosis risk: a prospective nested case-control investigation from the Nurses' Health Study II.
Shah DK; Correia KF; Harris HR; Missmer SA
Hum Reprod; 2013 Feb; 28(2):315-21. PubMed ID: 23188112
[TBL] [Abstract][Full Text] [Related]
16. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte membrane fatty acids and breast cancer risk: a prospective analysis in the nurses' health study II.
Hirko KA; Chai B; Spiegelman D; Campos H; Farvid MS; Hankinson SE; Willett WC; Eliassen AH
Int J Cancer; 2018 Mar; 142(6):1116-1129. PubMed ID: 29071721
[TBL] [Abstract][Full Text] [Related]
19. Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications.
Macciò A; Madeddu C; Gramignano G; Mulas C; Floris C; Massa D; Astara G; Chessa P; Mantovani G
J Mol Med (Berl); 2010 Jul; 88(7):677-86. PubMed ID: 20339829
[TBL] [Abstract][Full Text] [Related]
20. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
